Abstract
Background: Identification of targetable biology in breast cancer is an unmet need, particularly for triple negative breast cancer (TNBC) where patient outcome is poor and there are few clinically approved targeted therapies. Here, we identify the anion channel GPR89, to be a novel breast cancer oncogene relevant in TNBC and other breast cancer subtypes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
